KOMBINATORISCHE KREBSBEHANDLUNG
European patent · EP2603222 · In force
Register entry
- Publication number
- EP2603222
- Application number
- EP11815949
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Aug 11, 2011
- Published
- Jun 19, 2013
- Granted
- Oct 17, 2018
- Protection ends at the latest
- Aug 10, 2031
- Next annual fee due
- Aug 31, 2027
- IPC classes
- A61K 31/706 (2006.01)A61K 31/7056 (2006.01)A61P 35/00 (2006.01)A61P 35/02 (2006.01)C07H 19/056 (2006.01)C07H 19/12 (2006.01)A61K 45/06 (2006.01)
- Priority
- CA 2712747 11.08.2010
- PCT application
- PCT/CA2011/000908 11.08.2011
- PCT publication
- WO2012/019284 16.02.2012
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Sep 1, 2026
Next annual fee due on
- Next annual fee due on
- 31.08.2026 → 31.08.2027
Published in Swissreg on 01.09.2026
- Sep 1, 2025
Next annual fee due on
- Next annual fee due on
- 31.08.2025 → 31.08.2026
Published in Swissreg on 01.09.2025
- Sep 3, 2024
Next annual fee due on
- Next annual fee due on
- 31.08.2024 → 31.08.2025
Published in Swissreg on 03.09.2024
- Sep 1, 2023
Change
Published in Swissreg on 01.09.2023
- Sep 6, 2022
Change
Published in Swissreg on 06.09.2022
- Apr 16, 2019
Agent entered
- Representative
- Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex
Published in Swissreg on 16.04.2019
- Oct 17, 2018
Granted
Published in Swissreg on 17.10.2018
Parties
Inventor
Dollard des Ormeaux, Québec H9A 3G3, CA
Montreal, Québec H3V 1H3, CA
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.